Revance Therapeutics Inc
NASDAQ:RVNC
Intrinsic Value
The intrinsic value of one
RVNC
stock under the Base Case scenario is
4.18
USD.
Compared to the current market price of 3.65 USD,
Revance Therapeutics Inc
is
Undervalued by 13%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Revance Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Revance Therapeutics Inc
Earnings Waterfall
Revance Therapeutics Inc
The intrinsic value of one
RVNC
stock under the Base Case scenario is
4.18
USD.
Compared to the current market price of 3.65 USD,
Revance Therapeutics Inc
is
Undervalued by 13%.